NVO vs. MYTHY

Last updated Jun 13, 2026

NVO (Novo Nordisk A/S) and MYTHY (Mytilineos Holdings SA ADR) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while MYTHY operates in Conglomerates (Industrials).

Performance

NVO vs. MYTHY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novo Nordisk A/S (NVO) and Mytilineos Holdings SA ADR (MYTHY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

NVO

• 1D: -0.18%
• 1M: -4.19%
• YTD: -10.74%
• 6M: -9.50%
• 1Y: -42.47%
• 3Y*: -15.59%
• 5Y*: 2.92%
• 10Y*: 7.56%

MYTHY

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

NVO vs. MYTHY - Yearly Performance Comparison

	2026 (YTD)
NVO Novo Nordisk A/S	4.79%
MYTHY Mytilineos Holdings SA ADR	0.00%

Fundamentals

Market Cap NVO : $195.21B MYTHY : $8.32B
EPS NVO : DKK 27.42 MYTHY : €2.95
PE Ratio NVO : 10.34 MYTHY : 17.11
PS Ratio NVO : 3.85 MYTHY : 1.38
Total Revenue (TTM) NVO : DKK 327.80B MYTHY : €5.21B
Gross Profit (TTM) NVO : DKK 268.30B MYTHY : €667.88M
EBITDA (TTM) NVO : DKK 181.54B MYTHY : €692.66M

Return for Risk

NVO vs. MYTHY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVO

NVO Risk / Return Rank: 12
NVO Sharpe Ratio Rank: 9
NVO Sortino Ratio Rank: 12
NVO Omega Ratio Rank: 10
NVO Calmar Ratio Rank: 12
NVO Martin Ratio Rank: 16

MYTHY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVO vs. MYTHY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Mytilineos Holdings SA ADR (MYTHY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NVO	MYTHY	Difference
Sharpe ratio: Return per unit of total volatility	-0.84	—	—
Sortino ratio: Return per unit of downside risk	-1.05	—	—
Omega ratio: Gain probability vs. loss probability	0.85	—	—
Calmar ratio: Return relative to maximum drawdown	-0.80	—	—
Martin ratio: Return relative to average drawdown	-1.18	—	—

Drawdowns

NVO vs. MYTHY - Drawdown Comparison

The maximum NVO drawdown since its inception was -74.70%, which is greater than MYTHY's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for NVO and MYTHY.

Drawdown Indicators

	NVO	MYTHY	Difference
Max Drawdown Largest peak-to-trough decline	-74.70%	0.00%	-74.70%
Max Drawdown (1Y) Largest decline over 1 year	-54.34%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-74.70%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-74.70%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-74.70%	—	—
Current Drawdown Current decline from peak	-68.11%	0.00%	-68.11%
Average Drawdown Average peak-to-trough decline	-17.79%	0.00%	-17.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	37.62%	—	—

Volatility

Volatility by Period

	NVO	MYTHY	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.68%	—	—
Volatility (6M) Calculated over the trailing 6-month period	38.04%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	51.88%	0.00%	+51.88%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	38.33%	0.00%	+38.33%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.56%	0.00%	+32.56%

Dividends

NVO vs. MYTHY - Dividend Comparison

NVO's dividend yield for the trailing twelve months is around 4.11%, while MYTHY has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MYTHY Mytilineos Holdings SA ADR	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	4.11%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Financials

NVO vs. MYTHY - Profitability Comparison

The chart below illustrates the profitability comparison between Novo Nordisk A/S and Mytilineos Holdings SA ADR over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

MYTHY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Mytilineos Holdings SA ADR reported a gross profit of 180.41M and revenue of 1.80B. Therefore, the gross margin over that period was 10.0%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

MYTHY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Mytilineos Holdings SA ADR reported an operating income of 142.56M and revenue of 1.80B, resulting in an operating margin of 7.9%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

MYTHY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Mytilineos Holdings SA ADR reported a net income of 126.88M and revenue of 1.80B, resulting in a net margin of 7.0%.